Survival factors in lung cancer patients with mutations in the PROS1 , SERPINC1 , F2 , and F5 genes
Oncotarget · 02.11.2026 · 17 (1) · 489-501
DOI: 10.18632/oncotarget.28914 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncotarget, erschienen am 02.11.2026. Verfasst von Ryan Brownlee und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Lung Neoplasms, Mutation, Antithrombin III. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Brownlee, R., Birla, A., Bui, H., Ahmad, R., Zhang, D., Ji, A., & Raval, G. (2026). Survival factors in lung cancer patients with mutations in the PROS1 , SERPINC1 , F2 , and F5 genes. Oncotarget, 17(1), 489-501. https://doi.org/10.18632/oncotarget.28914
Vancouver
Brownlee R, Birla A, Bui H, Ahmad R, Zhang D, Ji A, et al. Survival factors in lung cancer patients with mutations in the PROS1 , SERPINC1 , F2 , and F5 genes. Oncotarget. 2026;17(1):489-501. doi:10.18632/oncotarget.28914
BibTeX
@article{Brownlee2026,
author = {Brownlee, Ryan and Birla, Aditya and Bui, Hung and Ahmad, Raniya and Zhang, Dongyu and Ji, Andrew and Raval, Girindra},
title = {Survival factors in lung cancer patients with mutations in the PROS1 , SERPINC1 , F2 , and F5 genes},
journal = {Oncotarget},
year = {2026},
volume = {17},
number = {1},
pages = {489--501},
doi = {10.18632/oncotarget.28914}
}
EUVIMED